ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 686513 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 686513; 2) Community: the network communities that were significantly associated with the response to NSC 686513; 3) Molecule: the relationships between components within communities and NSC 686513; 4) MDR: the compounds that were significantly associated with the NSC 686513.

NSC Compound Enrichment Correlation
NSC 119754 Berbinium, 7,8,13,13a-tetradehydro-2,3:9,10-bis(methylenedioxy)-, chloride (8CI) 0.039909871171863 0.32406124
NSC 129185 Melbex 0.039909871171863 0.46343773
NSC 163664 Arsinothious acid, dimethyl-, 2,4-pyrimidinediyl ester (9CI) 0.039909871171863 0.35632973
NSC 165572 Pyrido[3,2-g]quinoline-2,5,8,10(1H,9H)-tetrone, 1,4,6-trimethyl- 0.039909871171863 0.0015433918
NSC 241240 Carboplatin 0.039909871171863 0.40817113
NSC 270057 Hydroxypristimerin 0.039909871171863 0.44563481
NSC 305767 2,4-Quinazolinediamine, 6-[(4-chlorophenyl)thio]- 0.039909871171863 0.46810382
NSC 337851 Pregna-1,4-diene-3,11,20-trione, 21-[[[[3,6-bis(dimethylamino)-9-acridinyl]thio]acetyl]oxy]-17-hydroxy- 0.039909871171863 0.54188345
NSC 339705 5H-Indeno[1,2-c]isoquinoline-5,11(6H)-dione, 6-(2-hydroxyethyl)- 0.039909871171863 0.46491148
NSC 357885 Biantrazole 0.039909871171863 0.27513583
Total:91  Current:71    [First] [Prev] [Next] [Last]